HealthCare Global Enterprises Limited (NSE:HCG)

NSE:HCG Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	25,454	25,454	22,229	19,121	16,944	13,978
Revenue Growth	14.51%	14.51%	16.25%	12.85%	21.22%	37.92%
Gross Profit Gross Profit Growth	9,254	9,254	11,910	10,475	9,198	7,521
Operating Income Operating Income Growth	2,216	2,216	1,780	1,555	1,355	795.46
Net Income Net Income Growth	137.6	137.6	444.1	481.55	293.49	537.33
Earnings Per Share EPS Growth	0.96	0.96	3.14	3.43	2.10	3.97
EPS Growth	-69.43%	-69.43%	-8.46%	63.33%	-47.10%	-

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	21,748	18,898	16,815	13,948
outside India outside India Growth	433.14	180.3	99.01	-
Total Total Growth	22,181	19,079	16,914	13,948

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	5,409	5,409	3,477	3,031	1,966	2,042
Total Debt Total Debt Growth	17,354	17,354	18,372	12,744	9,012	9,147
Net Cash (Debt) Net Cash Growth	-11,944	-11,944	-14,895	-9,713	-7,046	-7,105
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-83.33	-83.33	-105.27	-69.18	-50.43	-52.56

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	3,471	3,471	3,171	2,846	2,516	2,201
Capital Expenditures CapEx Growth	-2,921	-2,921	-2,089	-1,857	-1,332	-712.32
Free Cash Flow Free Cash Flow Growth	550	550	1,082	988.99	1,184	1,489
Free Cash Flow Growth	-49.19%	-49.19%	9.45%	-16.44%	-20.51%	74.97%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	36.36%	36.36%	53.58%	54.78%	54.28%	53.80%
Operating Margin	8.71%	8.71%	8.01%	8.13%	8.00%	5.69%
Pretax Margin	1.06%	1.06%	2.56%	3.54%	2.65%	6.28%
Profit Margin	0.54%	0.54%	2.00%	2.52%	1.73%	3.84%
FCF Margin	2.16%	2.16%	4.87%	5.17%	6.98%	10.65%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	726.60	569.87	170.10	97.72	124.40	69.83
Forward PE	76.78	65.80	79.65	62.39	47.99	125.83
P/FCF Ratio	181.78	142.57	69.79	47.58	30.85	25.20
PS Ratio	3.93	3.08	3.40	2.46	2.15	2.68

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error